Study of ALD-401 Via Intracarotid Infusion in Ischemic Stroke Subjects

Clinical trial NCT01273337 · UNKNOWN

Trial details

NCT number: NCT01273337
Sponsor: Aldagen
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Stroke Ischemic Stroke Stroke in Middle Cerebral Artery (MCA)

Start date: 2011-03-01
Primary completion: 2014-07-01
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.